Novo Nordisk A/S ADR (NVO)

Mar 25, 2025, 12:59 PM EDT - 8 hours ago

Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly

Mar 24, 2025, 1:23 PM EDT - 1 day ago

SAP Overtakes Novo Nordisk as Europe's Most Valuable Company

SAP

Mar 24, 2025, 11:23 AM EDT - 1 day ago

Novo Nordisk's $2 billion obesity deal

LLY

Mar 24, 2025, 8:07 AM EDT - 1 day ago

Novo Nordisk expands discounted Wegovy to all cash-paying US customers

Mar 24, 2025, 8:00 AM EDT - 1 day ago

Novo Nordisk expands Wegovy® $499-per-month offering to additional cash-paying patients via the Wegovy® savings offer

Mar 24, 2025, 6:21 AM EDT - 1 day ago

Novo Nordisk secures license to weight-loss drug candidate from China's United Labs

Mar 24, 2025, 6:02 AM EDT - 1 day ago

The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist

Mar 24, 2025, 5:20 AM EDT - 1 day ago

Germany's SAP overtakes Novo Nordisk as Europe's largest company

SAP

Mar 24, 2025, 2:36 AM EDT - 1 day ago

Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure

Mar 17, 2025, 2:48 PM EDT - 8 days ago

UK Pharma Industry Trade Association Restores Wegovy/Ozempic Maker Novo Nordisk's Membership After 2 Years Of Suspension

Mar 17, 2025, 11:17 AM EDT - 8 days ago

Novo Nordisk membership in UK pharma body restored after suspension

Mar 15, 2025, 9:12 AM EDT - 10 days ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk

Mar 14, 2025, 6:08 PM EDT - 11 days ago

Drugmakers agree to participate in second round of price negotiations

ABBV AZN GSK MRK TEVA

Mar 14, 2025, 9:00 AM EDT - 11 days ago

Novo Nordisk: Stock Plunges, But It May Be Time To Load Up

Mar 13, 2025, 10:31 AM EDT - 12 days ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk

Mar 13, 2025, 5:45 AM EDT - 12 days ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in Novo Nordisk A/S Lawsuit - NVO

Mar 12, 2025, 6:23 PM EDT - 13 days ago

Novo Nordisk sell-off is completely overdone, says Mizuho's Jared Holz

Mar 12, 2025, 6:22 PM EDT - 13 days ago

Final Trade: AAPL, NVO, ADBE, FCX

AAPL ADBE FCX

Mar 12, 2025, 6:23 AM EDT - 13 days ago

How a Novo Nordisk Foundation-funded project sparked ultra-processed food fight

Mar 11, 2025, 1:44 PM EDT - 14 days ago

Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests

Mar 11, 2025, 8:35 AM EDT - 14 days ago

Novo Nordisk's Combo Drug CagriSema Shows 16% Weight Reduction In Second Phase 3 Trial

Mar 10, 2025, 12:52 PM EDT - 15 days ago

Novo Nordisk: CagriSema Disappoints Again

Mar 10, 2025, 11:16 AM EDT - 15 days ago

Novo Nordisk shares fall on weight-loss drug trial

Mar 10, 2025, 10:31 AM EDT - 15 days ago

Novo Nordisk Stock Drops on New Obesity Drug Finding. Eli Lilly Stands to Gain.

Mar 10, 2025, 10:30 AM EDT - 15 days ago

NVO Weight Loss Drug Disappoints, RDFN Acquisition, Airline Price Targets Slashed

Mar 10, 2025, 10:12 AM EDT - 15 days ago

Novo Nordisk Shares Sink on Latest CagriSema Weight Loss Drug Study

Mar 10, 2025, 7:59 AM EDT - 15 days ago

Novo Nordisk shares slide 6% after weight loss drug trial disappoints

Mar 10, 2025, 7:26 AM EDT - 15 days ago

Novo Nordisk Shares Fall After Latest CagriSema Obesity Drug Trial Results

Mar 10, 2025, 7:11 AM EDT - 15 days ago

Novo Nordisk shares fall 5.5% after latest trial results for its next-generation weight loss drug

Mar 10, 2025, 6:33 AM EDT - 15 days ago

Novo Nordisk says trial with next-gen drug in diabetics shows 15.7% weight loss

Mar 7, 2025, 6:23 PM EST - 18 days ago

Buy Two Ideal March 'Safer' Dividend Dogs Of 34 Barron's 2025 Pro-Picks

AGNC AMAT ASIX BDX CRM EPD FLMI

Mar 7, 2025, 6:19 PM EST - 18 days ago

Final Trade: GOOGL, NVO, GDX, MP

GDX GOOG GOOGL MP

Mar 7, 2025, 10:58 AM EST - 18 days ago

NVO, LLY and AMGN Forecast – Pharma Stocks Look Mixed in Premarket

AMGN LLY

Mar 6, 2025, 4:28 AM EST - 19 days ago

Novo Nordisk to explore how GLP-1 drugs can help patients with addiction

Mar 5, 2025, 2:51 PM EST - 20 days ago

Novo Nordisk Drops Price of Weight-Loss Drug Wegovy for Some Patients Paying Out of Pocket

Mar 5, 2025, 1:11 PM EST - 20 days ago

Novo Nordisk cuts Wegovy prices in half for cash-paying consumers

Mar 5, 2025, 11:39 AM EST - 20 days ago

Novo Nordisk slashing price of Wegovy to $499 a month to uninsured following rival's move